NASDAQ:MBX | Cash Flow Statement | MBX Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$37.1M
2026-03-31-$23.52M-$20.21M$437,000.00-$97.1M$87.44M
2025-12-31-$22.06M-$18.3M$793,000.00-$129.97M$438,000.00
2025-09-30-$21.62M
2025-06-30-$19.41M
2025-03-31-$23.88M-$22.68M$30,000.00$3.23M$4,000.00
2024-12-31-$15.59M-$16.04M$92,000.00-$67.35M-$132,000.00
2024-09-30-$18.14M
2024-06-30-$15.86M
2024-03-31-$12.34M-$10.71M$273,000.00$15.43M$183,000.00
2023-12-31-$8.84M-$11.15M$55,000.00-$28.96M$19,000.00
2023-09-30-$10.16M
2023-06-30-$7.61M
2023-03-31-$5.95M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$86.97M-$79.95M$1.93M-$83.71M$189.59M
2024-12-31-$61.92M-$54.68M$874,000.00-$160.6M$234.1M
2023-12-31-$32.56M-$31.98M$129,000.00-$30.93M$69.22M